A detailed history of Arrow Mark Colorado Holdings LLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Arrow Mark Colorado Holdings LLC holds 1,062,734 shares of LEGN stock, worth $42.7 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares
1,062,734
Previous 1,046,739 1.53%
Holding current value
$42.7 Million
Previous $58.7 Million 19.83%
% of portfolio
0.62%
Previous 0.73%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$39.5 - $57.22 $631,802 - $915,233
15,995 Added 1.53%
1,062,734 $47.1 Million
Q1 2024

May 15, 2024

SELL
$55.06 - $69.99 $980,233 - $1.25 Million
-17,803 Reduced 1.67%
1,046,739 $58.7 Million
Q4 2023

Feb 14, 2024

SELL
$57.25 - $69.74 $556,985 - $678,500
-9,729 Reduced 0.91%
1,064,542 $64.1 Million
Q2 2023

Aug 14, 2023

BUY
$46.28 - $75.01 $128,519 - $208,302
2,777 Added 0.26%
1,074,271 $74.2 Million
Q1 2023

May 15, 2023

BUY
$43.42 - $57.37 $1.57 Million - $2.07 Million
36,061 Added 3.48%
1,071,494 $51.7 Million
Q4 2022

Feb 14, 2023

BUY
$38.8 - $55.46 $727,616 - $1.04 Million
18,753 Added 1.84%
1,035,433 $51.7 Million
Q3 2022

Nov 14, 2022

BUY
$38.15 - $57.1 $30.9 Million - $46.3 Million
811,110 Added 394.57%
1,016,680 $41.5 Million
Q2 2022

Aug 15, 2022

BUY
$33.54 - $55.0 $1.33 Million - $2.18 Million
39,589 Added 23.85%
205,570 $11.3 Million
Q1 2022

May 16, 2022

BUY
$31.02 - $48.18 $2.42 Million - $3.77 Million
78,160 Added 89.0%
165,981 $6.03 Million
Q1 2021

May 17, 2021

SELL
$23.55 - $32.4 $2.54 Million - $3.5 Million
-108,035 Reduced 55.16%
87,821 $2.55 Million
Q4 2020

Feb 16, 2021

BUY
$25.8 - $32.39 $3.76 Million - $4.72 Million
145,856 Added 291.71%
195,856 $5.52 Million
Q2 2020

Aug 14, 2020

BUY
$36.1 - $42.56 $1.81 Million - $2.13 Million
50,000 New
50,000 $2.13 Million

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.73B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Arrow Mark Colorado Holdings LLC Portfolio

Follow Arrow Mark Colorado Holdings LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.